1. A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol. Issue 3 (18th March 2021) Authors: Spierings, Julia; van Rhenen, Anna; Welsing, Paco MW; Marijnissen, Anne CA; De Langhe, Ellen; Del Papa, Nicoletta; Dierickx, Daan; Gheorghe, Karina R; Henes, Joerg; Hesselstrand, Roger; Kerre, Tessa; Ljungman, Per; van de Loosdrecht, Arjan A; Marijt, Erik WAF; Mayer, Miro; Schmalzing, Marc; Schro... Journal: BMJ open Issue: Volume 11:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A2.12 Phenotype Changes of Blood Eosinophils Reflect Activity and Severity in Systemic Sclerosis. (25th February 2013) Authors: Wuttge, Dirk M; Andreasson, Annika; Tufvesson, Ellen; Scheja, Agneta; Hesselstrand, Roger; Truedsson, Lennart Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 1(2013) Page Start: A8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension. (30th March 2021) Authors: Wuttge, Dirk M; Carlsen, Anting L; Teku, Gabriel; Wildt, Marie; Rådegran, Göran; Vihinen, Mauno; Heegaard, Niels H H; Hesselstrand, Roger Journal: Rheumatology Issue: Volume 61:Number 1(2022) Page Start: 309 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ. (14th October 2019) Authors: Andréasson, Kristofer; Rådegran, Göran; Brunnström, Hans; Wuttge, Dirk M; Hesselstrand, Roger Journal: Rheumatology Issue: Volume 59:Number 5(2020) Page Start: 1177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗